Pfizer CTI Call for Proposals

Pfizer CTI is issuing a call for proposals. See the attached flyer for full information.

For consideration, submit a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic. Pre-proposals submitted to Pfizer CTI will be reviewed on a rolling basis.

For more information about submitting a pre-proposal, please contact Shreya Sawant at TIDO.alliances@childrens.harvard.edu.

For further information about CTI areas of focus, please contact Anthony Barry at anthony.b.barry@pfizer.com.

Deadline:

  • Non-confidential pre-proposal due to TIDO – Sep. 21